Gene · 634
Papers3,222
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,222
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Moving the needle on immune checkpoint inhibitors with novel targets: are we being TIMid or LAGging behind? | Oncologist | 2025 | 40631775 | PubTator, text mining | PubMed |
| PANoptosis-driven molecular stratification in esophageal squamous cell carcinoma: A multi-omics prognostic model and FGFR-Targeted therapeutic validation. | Comput Biol Med | 2025 | 40628169 | PubTator, text mining | PubMed |
| Proteomic Landscape of Colorectal Cancer Derived Liver Metastasis Reveals Three Distinct Phenotypes With Specific Signaling and Enhanced Survival. | Mol Cell Proteomics | 2025 | 40617497 | PubTator, text mining | PubMed |
| Therapeutic potential of TIM-3 inhibition in cancer, viral infections, and autoimmune disorders. | Int J Biochem Cell Biol | 2025 | 40609833 | PubTator, text mining | PubMed |
| Respiratory virus-induced bacterial dysregulation in pediatric airway tissue and the dual actions of Echinacea in reducing complications. | Front Pharmacol | 2025 | 40520162 | PubTator, text mining | PubMed |
| CEACAM1 as a mediator of B-cell receptor signaling in mantle cell lymphoma. | Nat Commun | 2025 | 40436855 | PubTator, text mining | PubMed |
| Microbial metabolite ammonia disrupts TGF-β signaling to promote colon cancer. | J Biol Chem | 2025 | 40311681 | PubTator, text mining | PubMed |
| The potential crosstalk genes and molecular mechanisms between systemic lupus erythematosus and periodontitis. | Front Genet | 2025 | 40309038 | PubTator, text mining | PubMed |
| Development of a radiomic model to predict CEACAM1 expression and prognosis in ovarian cancer. | Sci Rep | 2025 | 40307488 | PubTator, text mining | PubMed |
Corrigendum to "Novel Thiosemicarbazones Inhibit Lysine-Rich Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 (CEACAM1) Coisolated (LYRIC) and the LYRIC-Induced Epithelial- Mesenchymal Transition via Upregulation of N-Myc Downstream-Regulated Gene 1 (NDRG1)". | Mol Pharmacol | 2025 | 40239535 | PubTator, text mining | PubMed |
| Multimodal sequencing of neoadjuvant nivolumab treatment in hepatocellular carcinoma reveals cellular and molecular immune landscape for drug response. | Mol Cancer | 2025 | 40205519 | PubTator, text mining | PubMed |
| Clinical outcomes and safety of combined calcitriol and bisphosphonates in treating postmenopausal osteoporosis: a retrospective cohort study. | J Orthop Surg Res | 2025 | 40205415 | PubTator, text mining | PubMed |
| Relationship between serum CEACAM1 levels and prognosis and temozolomide chemotherapy sensitivity in patients undergoing neuroendoscopic transsphenoidal pituitary tumor resection. | Pak J Pharm Sci | 2025 | 40188475 | PubTator, text mining | PubMed |
| Mediators of the causal associations between protein ratios and ischemic stroke: a two-step Mendelian randomization study. | Neurol Res | 2025 | 40181221 | PubTator, text mining | PubMed |
| A two-transcript classifier model for assessing disease activity in patients with ulcerative colitis: A discovery and validation study. | Dig Liver Dis | 2025 | 40069026 | PubTator, text mining | PubMed |
| Tacrolimus (FK506) promotes placentation and maternal-fetal tolerance through modulating FASN-CEACAM1 pathway. | Front Immunol | 2025 | 40046057 | PubTator, text mining | PubMed |
| Effect of Sceptridium ternatum extract (STE) on radiation-induced pulmonary fibrosis by inhibiting cell adhesion factor CEACAM1. | J Ethnopharmacol | 2025 | 40015535 | PubTator, text mining | PubMed |
| Immune landscape and novel therapeutic targets of epidermal growth factor receptor and anaplastic lymphoma kinase wild type never-smoker lung adenocarcinoma. | Lung Cancer | 2025 | 39970729 | PubTator, text mining | PubMed |
| sCEACAM-1 levels in maternal blood in case of threatened preterm birth. | Eur J Obstet Gynecol Reprod Biol | 2025 | 39970542 | PubTator, text mining | PubMed |
| Identification and validation of a novel autoantibody biomarker panel for differential diagnosis of pancreatic ductal adenocarcinoma. | Front Immunol | 2025 | 39949781 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/634/papers?page=6